Related Experiment Video

Updated: Apr 12, 2026

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

30.1K

Clinical utilities of aromatase inhibitors in breast cancer

Saranya Chumsri1

  • 1Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.

International Journal of Women'S Health
|May 26, 2015
PubMed

Insights

Aromatase inhibitors (AIs) block estrogen production, offering clinical benefits for breast cancer treatment. This review covers AI mechanisms, types, and applications in various breast cancer settings.

Area of Science:

  • Endocrinology
  • Oncology

Background:

  • Aromatase is a key enzyme in estrogen biosynthesis, converting androgens to estrogens.
  • Estrogen plays a significant role in the development and progression of certain breast cancers.

Purpose of the Study:

  • To review the mechanism of action of aromatase inhibitors (AIs).
  • To classify the different types of AIs.
  • To discuss the clinical utilities of AIs in various breast cancer contexts.

Main Methods:

  • Literature review of aromatase inhibitors in breast cancer treatment.
  • Analysis of current clinical applications and mechanisms of action.

Main Results:

  • Three main AIs are currently in clinical use: anastrozole, letrozole, and exemestane.
  • AIs are utilized across a spectrum of breast cancer management, including chemoprevention, adjuvant therapy, and treatment of metastatic disease.

Conclusions:

  • Aromatase inhibition is a crucial therapeutic strategy in managing hormone-sensitive breast cancers.
  • Understanding AI mechanisms and applications is vital for optimizing breast cancer care.
Keywords:
aromatase inhibitorbreast cancerendocrine therapy

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

11.0K
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
Cancer Therapies02:49

Cancer Therapies

3.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
844
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69